Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human studies have uncovered a host of possible uses for drugs that stimulate the ubiquitous GLP-1 receptors. https://t.co/Gfp1ougjPT https://t.co/zg5E3TRG9B
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2024 – Oct 2025Where it's discussed
-
X / Twitter163 posts
-
News33 articles
-
YouTube8 videos
-
Facebook6 posts
-
Blogs3 articles
AI synopsis
What people are saying
The collective discussions demonstrate strong enthusiasm and interest, with many users citing studies from reputable journals like JAMA, and emphasizing the transformative potential of GLP-1 receptor agonists for conditions like addiction and Alzheimer's. The tone and language indicate a belief in their future impact, discussion of ongoing research, and skepticism about exaggerated claims, reflecting both excitement and critical evaluation.
Most discussions support the potential of GLP-1 receptor agonists in treating various conditions, emphasizing the promising nature of the research.
Posts exhibit high curiosity, highlighting ongoing clinical trials and potential new uses for these drugs.
Many comments reference specific studies, cite articles, and discuss implications, showing deep involvement.
The general tone suggests these findings could significantly influence medical practices and drug repurposing debates.
Abstract in brief
- GLP-1 receptor agonists like semaglutide are primarily used for diabetes and weight loss, but recent research suggests they might also help treat addiction, Alzheimer's disease, and other conditions.
- These drugs work by activating GLP-1 receptors in the brain, which could influence appetite control, memory, and addictive behaviors.
- While promising, more studies are needed to understand how effective these medications are for these new uses and whether they can be safely used beyond their current indications.
Top posts
Most liked on X and BlueskyGLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are underway to explore their potential benefits. #GLP1receptoragonists #medicalresearch https://t.co/mLm27atd0E https://t.co/BMMzc7JPVx
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA | JAMA Network https://t.co/2vngzWa7B2
GLP-1受容体アゴニストの依存症、アルツハイマー病、パーキンソン病における治療薬としての可能性について JAMA 2024 https://t.co/W6tN4yLk2Q
Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<dependencia alcohol / tabaco / coca 6⃣ Efecto neuroprotector y < Parkinson https://t.co/526hXSK9hp
Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human studies have uncovered a host of possible uses for drugs that stimulate the ubiquitous GLP-1 receptors. https://t.co/YSePkf0LLJ https://t.co/3FkOYoIktg
All mentions
Understanding Ozempic: From Diabetes Treatment to Potential Neurotherapeutic Uses
Ozempic is widely known for diabetes and weight loss, but recent research suggests it may also treat addiction and Alzheimer's disease by activating brain GLP-1 receptors. More studies are needed to confirm these…
Exploring the Potential of GLP-1 Receptor Agonists for Treating Addiction and Alzheimer's
GLP-1 receptor agonists like semaglutide, primarily used for diabetes and weight loss, may also help treat addiction and Alzheimer's by influencing brain functions related to appetite, memory, and behavior. More…
GLP-1 Based Therapies: Potential for Addiction Treatment Beyond Diabetes
Originally developed for diabetes, GLP-1 drugs are now used globally for weight loss. Recent research shows that GLP-1 analogues like Exendin-4 may reduce drug reward and addiction by affecting brain reward pathways.
Advances in GLP-1 Receptor Agonists for Medical Treatments
Originally developed for diabetes, GLP-1 receptor agonists like semaglutide are now explored for treating addiction, Alzheimer's, and more by activating brain receptors that influence appetite and memory. Further…
Exploring the Broader Potential of GLP-1 Receptor Agonists in Medical Treatment
Ozempic, originally for diabetes, is now popular for weight loss, but recent research suggests GLP-1 receptor agonists like semaglutide may also treat addiction and Alzheimer's by influencing brain functions. Further…
Ozempic Overview Effects Risks and Uses in Weight Loss and Diabetes
Ozempic is a widely recognized medication originally developed for diabetes management. It has gained popularity for aiding weight loss, but potential side effects and mechanisms are important to understand. Recent…
The Truth About Ozempic and Its Broader Medical Potential
Ozempic is widely known as a treatment for diabetes and weight loss. Recent research suggests GLP-1 receptor agonists like semaglutide could also treat addiction, Alzheimer's, and other conditions by influencing brain…
The Science Behind Ozempic for Weight Loss and Potential New Uses
Ozempic was originally developed for diabetes but has gained popularity for weight loss. Recent research indicates its potential to treat addiction, Alzheimer's, and other conditions by activating GLP-1 receptors in the…
@kidney_boy Could work? They are looking into it for all addictions, not just overeating https://t.co/G2QoUOcj2Z
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
@MaraStrega Не забудьте, что агонисты ГЛП-1 помогают бороться с алкоголизмом, наркотической зависимостью, бросить курить, а также скорее всего с деменцией. https://t.co/UuxAGFQg16
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? https://t.co/036v7Trq67
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA | JAMA Network https://t.co/srofzUYUQz
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA | JAMA Network https://t.co/srofzUYUQz
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
RT @scottisaacsmd: GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are…
GLP-1 receptor agonists like #semaglutide show promise in treating addiction, Alzheimer's, and more. Clinical trials are underway to explore their potential benefits. #GLP1receptoragonists #medicalresearch https://t.co/mLm27atd0E https://t.co/BMMzc7JPVx
RT @drjorfer: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA |…
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA | JAMA Network
RT @DrJavierCrespo: Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<depe…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human studies have uncovered a host of possible uses for drugs that stimulate the ubiquitous GLP-1 receptors. https://t.co/YSePkf0LLJ https://t.co/3FkOYoIktg
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
RT @NeilFlochMD: Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA…
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA | JAMA Network https://t.co/2vngzWa7B2
Blockbuster Obesity Drugs Have Potential New Uses https://t.co/RHrzpHce71
Blockbuster Obesity Drugs Have Potential New Uses https://t.co/djwWZM6kD8
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
Blockbuster Obesity Drugs Have Potential New Uses https://t.co/VqXGdTmZpT
Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA | JAMA Network https://t.co/gZ6PuVAcDb
Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA | @iapindia @AdolHealthIAP @fogsiofficial @IPAWorldorg @Asiapacific_Ped @MoHFW_INDIA https://t.co/BlBIFmaSrN
Blockbuster Obesity Drugs Have Potential New Uses https://t.co/fidR5QgHB7
Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? https://t.co/mWsRnmepQ2
https://t.co/i5TSlxVUoB #uthealthhouston #mentalhealth #psychiatry
RT @mdballesteros: Blockbuster Obesity Drugs Have Potential New Uses. Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzhe…
RT @FarmaMadridAP: (JAMA)
RT @FarmaMadridAP: (JAMA)
(JAMA)
I’d also read this. https://t.co/GGUHov9BO2 https://t.co/PEgbeYXEpp https://t.co/4j9MA6qOmL
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @DrJavierCrespo: Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<depe…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @ksktkht8: GLP-1受容体アゴニストの依存症、アルツハイマー病、パーキンソン病における治療薬としての可能性について JAMA 2024 https://t.co/W6tN4yLk2Q
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @CarlosdelRio7: Blockbuster Obesity Drugs Have Potential New Uses https://t.co/nEVLKbzRDt @JAMA_current
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @DrJavierCrespo: Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<depe…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @DrJavierCrespo: Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<depe…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @DrJavierCrespo: Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<depe…
RT @mdballesteros: Blockbuster Obesity Drugs Have Potential New Uses. Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzhe…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @mdballesteros: Blockbuster Obesity Drugs Have Potential New Uses. Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzhe…
https://t.co/217xEuJDMB
Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? | Diabetes | JAMA | JAMA Network https://t.co/bydCxTJcEI
RT @vbaosv: Creo que habrá que vigilar con lupa las "evidencias" que sustenten que estos medicamentos valgan para "casi todo" Blockbuster…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @pash22: Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? https://t.co/pJwHlSIJX…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
https://t.co/oScJQCJrMo Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? @JAMANetwork
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
Mohli by agonisté receptoru GLP-1, jako je semaglutid, léčit závislost, Alzheimerovu chorobu a další nemoci? | | JAMA https://t.co/5WDxKHDbKo
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @mdballesteros: Blockbuster Obesity Drugs Have Potential New Uses. Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzhe…
RT @mdballesteros: Blockbuster Obesity Drugs Have Potential New Uses. Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzhe…
Blockbuster Obesity Drugs Have Potential New Uses. Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? https://t.co/pJeU0SRjtJ
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? https://t.co/pJwHlSIJXB via @RitaRubin
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @ksktkht8: GLP-1受容体アゴニストの依存症、アルツハイマー病、パーキンソン病における治療薬としての可能性について JAMA 2024 https://t.co/W6tN4yLk2Q
RT @DrJavierCrespo: Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<depe…
Creo que habrá que vigilar con lupa las "evidencias" que sustenten que estos medicamentos valgan para "casi todo" Blockbuster Obesity Drugs Have Potential New Uses https://t.co/KC2PhCZd8r
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
@JAMA_current "Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions?" No. Such claims are, of course, pure marketing. The same strategy has been in use from Day 1: pharmaceutical companies hire "researchers" to write fake articles.
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @ksktkht8: GLP-1受容体アゴニストの依存症、アルツハイマー病、パーキンソン病における治療薬としての可能性について JAMA 2024 https://t.co/W6tN4yLk2Q
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @ksktkht8: GLP-1受容体アゴニストの依存症、アルツハイマー病、パーキンソン病における治療薬としての可能性について JAMA 2024 https://t.co/W6tN4yLk2Q
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
GLP-1受容体アゴニストの依存症、アルツハイマー病、パーキンソン病における治療薬としての可能性について JAMA 2024 https://t.co/W6tN4yLk2Q
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @DrJavierCrespo: Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<depe…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @DrBenjaminHorne: Blockbuster Obesity Drugs Have Potential New Uses @JAMA_current https://t.co/quEUx2J9NU
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
Los aGLP1, ¿valen para todo? 1⃣Control DMII 2⃣ < Peso 3⃣ < riesgo vascular 4⃣< morbilidad IC con FE conservada 5⃣¿<dependencia alcohol / tabaco / coca 6⃣ Efecto neuroprotector y < Parkinson https://t.co/526hXSK9hp
Blockbuster Obesity Drugs Have Potential New Uses https://t.co/NlZhpZrIeI
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
RT @JAMA_current: Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human…
Could GLP-1 receptor agonists like semaglutide treat addiction, Alzheimer disease, and other conditions? Animal and human studies have uncovered a host of possible uses for drugs that stimulate the ubiquitous GLP-1 receptors. https://t.co/Gfp1ougjPT https://t.co/zg5E3TRG9B
RT @DrBenjaminHorne: Blockbuster Obesity Drugs Have Potential New Uses @JAMA_current https://t.co/quEUx2J9NU
{Fighting Stigma} Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and ...: Yammine, an associate professor in the department of psychiatry and behavioral sciences at UTHealth Houston, found some animal studies… https://t.co/fhiL1BNt2T
Blockbuster Obesity Drugs Have Potential New Uses @JAMA_current https://t.co/quEUx2J9NU
Blockbuster Obesity Drugs Have Potential New Uses https://t.co/nEVLKbzRDt @JAMA_current
My latest for @JAMA_current: Blockbuster Obesity Drugs Have Potential New Uses https://t.co/UUOmZMH2g3
BM
ML